drugset / Trial / NCT02846675
Safety and Efficacy of Autologous SVF Cells in Treating Patients With Osteoarthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
it's a self-control, double blind study of autologous adipose-derived stromal vascular fraction (SVF) to treat 50 osteoarthritic knees of grade II or III (K-L scale) under IRB-approved protocol in a feasibility and safety study.
Timeline
- Start
- 2014-11-01
- Primary completion
- 2017-07-31
- Completion
- 2018-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rexlemestrocel-L | Cell therapy | 5e+07 cells | Other |